Phase I Study of Transfected Cancer Cells Expressing the Interleukin-2 Gene Product in Limited Stage Small Cell Lung Cancer. University of Miami, Miami, Florida

This publication has 48 references indexed in Scilit:

• MHC Class I Deficiency: Susceptibility to Natural Killer (NK) Cells and Impaired NK Activity
  Science, 1991
• Correlation of in vitro drug sensitivity testing of long-term small cell lung cancer cell lines with response and survival
  European Journal of Cancer and Clinical Oncology, 1990
• Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer.
  Journal of Clinical Investigation, 1990
• Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response
  Cell, 1990
• Murine interleukin-4 displays potent anti-tumor activity in vivo
  Cell, 1989
• Clonal Expansion Versus Functional Clonal Inactivation: A Costimulatory Signalling Pathway Determines the Outcome of T Cell Antigen Receptor Occupancy
  Annual Review of Immunology, 1989
• Repetitive Weekly Cycles of Recombinant Human Interleukin-2: Responses of Renal Carcinoma With Acceptable Toxicity1
  JNCI Journal of the National Cancer Institute, 1988
• Detection of small cell lung cancer metastases in bone marrow aspirates using monoclonal antibody directed against neuroendocrine differentiation antigen.
  Journal of Clinical Pathology, 1988
• Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors
  European Journal of Immunology, 1988
• Isolation and growth characteristics of continuous cell lines from small-cell carcinoma of the lung
  Cancer, 1980